The Future of Medicine is Data
At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new drugs to patient treatment decisions.
At 3pm (PST) on Tuesday the 10th of January at the Golden Gate Hotel, San Francisco, Thomas will discuss how finding the right treatment for every patient can only be achieved by the secure analysis of high-quality data, with data flowing freely yet securely between care and research.
WiFi SPARK is renewing its commitment to making sure that NHS patients can enjoy the very best festive TV and entertainment without worrying about the cost.
Last year's Budget set aside £2.1 billion for NHS IT, and the autumn statement confirmed the capital is still there, but it looks like most of the money is headed for Frontline Digitisation. The Highland Marketing advisory board considers how this pattern of putting money into health tech, taking it out again, shaking up the badging, and starting over impacts the market. 
Healthcare professionals at one of the world's leading children's hospitals will benefit from digital imaging tools that will enhance how they assess x-rays, CTs, MRIs and other scans that are crucial for effective diagnoses.
Black Country Pathology Services has seen its "biggest go-live to date" with the Clinisys laboratory information system that is being rolled-out to all of its laboratories.
Bayer moves ahead with the advancement of its comprehensive Radiology portfolio with progress on the development pipeline of new contrast agents as well as further partnerships in its digital business. The company announced today the presentation of new early clinical data for gadoquatrane, Bayer’s novel macrocyclic gadolinium-based compound currently in Phase II development, at the Radiological Society of North America (RSNA) Annual Meeting.